Please login to the form below

Not currently logged in
Email:
Password:

Roche, J&J and Novartis in hepatitis C diagnostics tie-up

Roche signs licensing agreements for Hepatitis C immunodiagnostics with J&J subsidiary Ortho-Clinical Diagnostics and Novartis

Swiss-based pharmaceutical group Roche has signed licensing agreements for Hepatitis C immunodiagnostics with J&J subsidiary Ortho-Clinical Diagnostics and Swiss-headquartered Novartis.

Roche, Ortho-Clinical and Novartis also agreed to settle all litigation related to licensed patents.

Roche will receive a worldwide royalty-bearing license under the deal, according to a Roche statement. Financial terms were not disclosed.

30th September 2008

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

The search for treatments for Parkinson’s disease
The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...
Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
Ditch the Label – it’s just me....
The impact of COVID-19 on clinical trials
As all industry sectors work to assess both the impact and the optimal path forward, the effects are expected to be diverse and long-lasting...

Infographics